The price of Orilissa is affected by multiple factors. High research and development costs, including extensive clinical trials for endometriosis treatment, significantly contribute.
Its manufacturing, packaging, and quality control processes also add to expenses. Additionally, as a patented drug with limited competition and targeting a niche patient population, these aspects further influence its pricing.

